WaisMed

Device for Rapid Intravascular Access

Health Tech & Life Sciences
Acquired (Inactive) by PerSys Medical on Dec 2004 - closed due to acquisition
Acquired Rosh Haayin Founded 1994
LinkedIn
Total raised
Stage
Acquired
Founded
1994
Headcount
1-10
HQ
Rosh Haayin
Sector
Health Tech & Life Sciences

About

WaisMed develops and manufactures medical devices for emergency and critical care applications. The company has developed an automatic, mechanical, disposable device for rapid intraosseous (IO) access into the vascular system. Its Bone Injection Gun is an IO infusioninjection system that is easy to use, safe, and also suitable for veterinary use. Based on a patented injection system, WaisMeds IO devices provide rapid, safe, and easy intravascular access through the bone marrow. Connection to standard infusion equipment is simple for administering fluids, medications, and blood products. In 2014 the company received FDA approval and a CE mark for the NIO, a new intraosseous medical device.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was WaisMed founded and what is its primary focus?
WaisMed was founded in February 1994. The company develops and manufactures medical devices for emergency and critical care applications, specifically focusing on rapid intraosseous (IO) access into the vascular system.
What is WaisMed's flagship product for intraosseous access?
WaisMed's flagship product is the Bone Injection Gun (B.I.G), an automatic, mechanical, disposable device for rapid intraosseous infusion and injection, also suitable for veterinary use.
When did WaisMed receive regulatory approvals for its NIO device?
In 2014, WaisMed received FDA approval and a CE mark for its new intraosseous medical device, the NIO.
What is the current status of WaisMed?
WaisMed is currently inactive, having been acquired by PerSys Medical in December 2004.
When was WaisMed acquired and by whom?
WaisMed was acquired in December 2004 by PerSys Medical.
What was the reported acquisition amount for WaisMed?
WaisMed was acquired for $1,000,000 in December 2004.
What markets does WaisMed target with its medical devices?
WaisMed targets the United States and Canada as its geographic markets, serving customers in Healthcare & Life Sciences, Healthcare Providers, and Government & City sectors.
What is a key feature of WaisMed's IO devices?
WaisMed's IO devices are based on a patented injection system, providing rapid, safe, and easy intravascular access through the bone marrow.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProvidersGovernment & City
Business model
B2BB2G

Highlights

1 Patents

Tags

medical-devicesvascularhospitalsveterinarymilitaryfirst-aid